Neogen Operating Cycle from 2010 to 2026

NEOG Stock  USD 10.61  0.19  1.76%   
Neogen's Operating Cycle is decreasing over the last several years with very volatile swings. Operating Cycle is estimated to finish at 274.21 this year. During the period from 2010 to 2026 Neogen Operating Cycle regressed destribution of quarterly values had coefficient of variationof  11.91 and r-value of (0.01). View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
241.23
Current Value
274.21
Quarterly Volatility
26.59709213
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Neogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 151.7 M, Interest Expense of 86.5 M or Total Revenue of 1.1 B, as well as many indicators such as Price To Sales Ratio of 1.21, Dividend Yield of 0.0 or PTB Ratio of 0.52. Neogen financial statements analysis is a perfect complement when working with Neogen Valuation or Volatility modules.
  
Build AI portfolio with Neogen Stock
Check out the analysis of Neogen Correlation against competitors.
For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.
The Operating Cycle trend for Neogen offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Neogen is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Neogen's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Neogen over the last few years. It is Neogen's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neogen's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Very volatile
   Operating Cycle   
       Timeline  

Neogen Operating Cycle Regression Statistics

Arithmetic Mean223.35
Geometric Mean222.00
Coefficient Of Variation11.91
Mean Deviation18.18
Median216.54
Standard Deviation26.60
Sample Variance707.41
Range111
R-Value(0.01)
Mean Square Error754.42
R-Squared0.0002
Significance0.96
Slope(0.07)
Total Sum of Squares11,318

Neogen Operating Cycle History

2026 274.21
2025 241.23
2024 209.77
2023 217.99
2022 185.28
2021 226.13
2020 216.59

About Neogen Financial Statements

Neogen stakeholders use historical fundamental indicators, such as Neogen's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Neogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Neogen's assets and liabilities are reflected in the revenues and expenses on Neogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Neogen. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 241.23  274.21 

Currently Active Assets on Macroaxis

When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:
Check out the analysis of Neogen Correlation against competitors.
For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Neogen have expansion opportunities? Factors like these will boost the valuation of Neogen. Anticipated expansion of Neogen directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Neogen demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth
(0.86)
Earnings Share
(2.78)
Revenue Per Share
4.054
Quarterly Revenue Growth
(0.03)
Return On Assets
(0)
Investors evaluate Neogen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Neogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Neogen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Neogen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Neogen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Neogen's market price signifies the transaction level at which participants voluntarily complete trades.